Prognostic Values of CD38+CD101+PD1+CD8+ T Cells in Pancreatic Cancer

ABSTRACTProgrammed death-1 (PD-1), a key immune checkpoint molecule, has been developed as an oncotherapy target for various carcinomas. However, treatment with anti-PD-1 elicited only a minimal ef...